. 1982 Jan 15;180(2):137-9.
- PMID: 7061309
Canine parvovirus infection potentiates canine distemper encephalitis attributable to modified live-virus vaccine
S Krakowka et al. J Am Vet Med Assoc. 1982.
Abstract
Twelve gnotobiotic dogs from 2 litters were allotted to 3 groups. Group A dogs received a modified-live polyvalent (canine distemper, adenovirus type 2, and parainfluenza virus and Leptospira -canicola-icterohemorrhagiae bacterin) vaccine 3 days prior to oral inoculation with canine parvovirus (CPV). Group B dogs received CPV alone. Group C dogs received 1 dose of vaccine only. In none of the 9 CPV-inoculated dogs did clinical signs of CPV infection develop, although high serum antibody titers for CPV developed in all of them. However, in 2 of the 5 CPV-inoculated vaccinates, canine distemper virus encephalomyelitis subsequently developed. The results suggested that CPV exerts an immunomodulating effect on canine immune responses and may be responsible for vaccination failures in dogs.
Similar articles
Development of a modified live, canine origin parvovirus vaccine.
Bass EP, Gill MA, Beckenhauer WH. Bass EP, et al. J Am Vet Med Assoc. 1982 Nov 1;181(9):909-13. J Am Vet Med Assoc. 1982. PMID: 7141990
Three-year duration of immunity in dogs following vaccination against canine adenovirus type-1, canine parvovirus, and canine distemper virus.
Gore TC, Lakshmanan N, Duncan KL, Coyne MJ, Lum MA, Sterner FJ. Gore TC, et al. Vet Ther. 2005 Spring;6(1):5-14. Vet Ther. 2005. PMID: 15906266 Clinical Trial.
Canine viral vaccines at a turning point--a personal perspective.
Carmichael LE. Carmichael LE. Adv Vet Med. 1999;41:289-307. doi: 10.1016/s0065-3519(99)80022-6. Adv Vet Med. 1999. PMID: 9890023 Free PMC article. Review.
[Canine parvovirus: recent knowledge of the origin and development of a viral pathogen].
Truyen U. Truyen U. Tierarztl Prax. 1994 Dec;22(6):579-84. Tierarztl Prax. 1994. PMID: 7716757 Review. German.
Cited by
Vaccination of Immunocompromised Cats.
Hartmann K, Möstl K, Lloret A, Thiry E, Addie DD, Belák S, Boucraut-Baralon C, Egberink H, Frymus T, Hofmann-Lehmann R, Lutz H, Marsilio F, Pennisi MG, Tasker S, Truyen U, Hosie MJ. Hartmann K, et al. Viruses. 2022 Apr 28;14(5):923. doi: 10.3390/v14050923. Viruses. 2022. PMID: 35632665 Free PMC article. Review.
Antibody Response to Canine Parvovirus Vaccination in Dogs with Hyperadrenocorticism Treated with Trilostane.
Bergmann M, Freisl M, Hartmann K, Speck S, Truyen U, Zablotski Y, Mayr M, Wehner A. Bergmann M, et al. Vaccines (Basel). 2020 Sep 19;8(3):547. doi: 10.3390/vaccines8030547. Vaccines (Basel). 2020. PMID: 32961758 Free PMC article.
The challenges in developing effective canine infectious respiratory disease vaccines.
Mitchell JA, Brownlie J. Mitchell JA, et al. J Pharm Pharmacol. 2015 Mar;67(3):372-81. doi: 10.1111/jphp.12380. Epub 2015 Mar 3. J Pharm Pharmacol. 2015. PMID: 25736813 Free PMC article. Review.
Canine distemper spillover in domestic dogs from urban wildlife.
Kapil S, Yeary TJ. Kapil S, et al. Vet Clin North Am Small Anim Pract. 2011 Nov;41(6):1069-86. doi: 10.1016/j.cvsm.2011.08.005. Vet Clin North Am Small Anim Pract. 2011. PMID: 22041204 Free PMC article. Review.
Immunodeficiencies caused by infectious diseases.
Sykes JE. Sykes JE. Vet Clin North Am Small Anim Pract. 2010 May;40(3):409-23. doi: 10.1016/j.cvsm.2010.01.006. Vet Clin North Am Small Anim Pract. 2010. PMID: 20471525 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
- The Lens - Patent Citations